Hillsborough, CA, United States of America

Glenn C Rice

This inventor holds 1 USPTO granted patent. Top assignee: The Picower Institute for Medical Research. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Glenn C Rice. Retrieved from https://idiyas.com/inventor/glenn-c-rice-m2v38u80

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Glenn C. Rice: Innovator in Fibrocyte-Based Vaccine Formulations

Introduction

Glenn C. Rice is a notable inventor based in Hillsborough, CA (US). He has made significant contributions to the field of medical research, particularly in the development of vaccine formulations. His innovative work focuses on utilizing fibrocytes to create effective immune responses against specific antigens.

Latest Patents

Glenn C. Rice holds 1 patent for his invention titled "Fibrocyte-based vaccine formulations." This patent discloses a method for establishing an immune response by administering a fibrocyte-based vaccine formulation. The formulation is made from isolated fibrocytes, which can be pulsed in culture with antigen peptides or proteins, or by fusing tumor cells with fibrocytes.

Career Highlights

Rice is affiliated with the Picower Institute for Medical Research, where he conducts his research and development activities. His work has the potential to advance vaccine technology and improve therapeutic strategies for various diseases.

Collaborations

One of his notable collaborators is Richard J. Bucala, with whom he has likely shared insights and expertise in the field of immunology and vaccine development.

Conclusion

Glenn C. Rice's contributions to fibrocyte-based vaccine formulations represent a significant advancement in medical research. His innovative approach may pave the way for new therapeutic options in immunology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…